Russell Investments Group Ltd. Has $2.66 Million Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Russell Investments Group Ltd. lessened its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 43,201 shares of the medical instruments supplier's stock after selling 7,265 shares during the period. Russell Investments Group Ltd. owned about 1.27% of Utah Medical Products worth $2,656,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Bard Associates Inc. boosted its stake in shares of Utah Medical Products by 1.3% in the fourth quarter. Bard Associates Inc. now owns 20,030 shares of the medical instruments supplier's stock valued at $1,237,000 after buying an additional 249 shares during the period. Wells Fargo & Company MN lifted its position in shares of Utah Medical Products by 24.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after acquiring an additional 384 shares during the period. Golden State Wealth Management LLC acquired a new stake in shares of Utah Medical Products during the 4th quarter worth $31,000. BNP Paribas Financial Markets increased its position in shares of Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock worth $75,000 after purchasing an additional 566 shares during the period. Finally, American Century Companies Inc. raised its stake in Utah Medical Products by 8.6% in the fourth quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier's stock valued at $500,000 after purchasing an additional 643 shares in the last quarter. Institutional investors and hedge funds own 69.60% of the company's stock.

Utah Medical Products Price Performance

UTMD traded up $0.89 on Wednesday, hitting $54.48. 1,038 shares of the stock were exchanged, compared to its average volume of 20,604. The firm has a market capitalization of $178.80 million, a price-to-earnings ratio of 13.79 and a beta of 0.17. Utah Medical Products, Inc. has a 12 month low of $51.71 and a 12 month high of $77.33. The business has a 50-day moving average of $56.85 and a two-hundred day moving average of $61.19.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th were paid a $0.305 dividend. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.22 annualized dividend and a dividend yield of 2.24%. Utah Medical Products's payout ratio is 30.89%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.